<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for RGLS</title>
    <link />
    <description>Headlines for Regulus Therapeutics Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Regulus Therapeutics CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435161-regulus-therapeutics-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 20:17:04 GMT</pubDate>
    </item>
    <item>
      <title>Regulus Therapeutics: Strong Balance Sheet As It Moves Into Clinical Development</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1406291-regulus-therapeutics-strong-balance-sheet-as-it-moves-into-clinical-development.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 06 May 2013 14:40:55 GMT</pubDate>
    </item>
    <item>
      <title>3 Investment Ideas for Biotech Investors</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/30/3-investment-ideas-for-biotech-investors/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 30 Apr 2013 21:20:04 GMT</pubDate>
    </item>
    <item>
      <title>3 Stocks Near 52-Week Highs Worth Selling</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/18/3-stocks-near-52-week-highs-worth-selling-27/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 18 Apr 2013 12:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Why Regulus Therapeutics Is Poised to Keep Plunging</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/05/why-regulus-therapeutics-is-poised-to-keep-plungin/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 05 Apr 2013 12:45:43 GMT</pubDate>
    </item>
    <item>
      <title>Sangamo Bioscience: The Impending Failure In HIV</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1269121-sangamo-bioscience-the-impending-failure-in-hiv.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 13 Mar 2013 06:26:29 GMT</pubDate>
    </item>
    <item>
      <title>Regulus Therapeutics' Management Presents at Cowen and Company 33rd Annual Healthcare Conference (Tr</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1248361-regulus-therapeutics-management-presents-at-cowen-and-company-33rd-annual-healthcare-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 05 Mar 2013 14:25:12 GMT</pubDate>
    </item>
    <item>
      <title>Roundtable: 5 Disruptive Technologies Leading the Next Medical Revolution</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/26/5-disruptive-technologies-leading-the-next-medical/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Feb 2013 14:27:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Bubble: Alnylam Triples Despite Setbacks And Insider Selling</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1220311-biotech-bubble-alnylam-triples-despite-setbacks-and-insider-selling.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 25 Feb 2013 09:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Regulus Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1209431-regulus-therapeutics-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 20 Feb 2013 22:56:00 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/12/12/3203673/stocks-hitting-52-week-highs.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 28 Dec 2012 11:14:19 GMT</pubDate>
    </item>
    <item>
      <title>1 Small Pharma Proving That Partnerships Pay</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/12/1-small-pharma-proving-that-partnerships-pay/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 12 Dec 2012 13:43:00 GMT</pubDate>
    </item>
    <item>
      <title>Regulus Therapeutics' CEO Discusses Q3 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1019271-regulus-therapeutics-ceo-discusses-q3-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 19 Nov 2012 20:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Alnylam: Further Evidence That The Stock Is Overvalued</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1017311-alnylam-further-evidence-that-the-stock-is-overvalued.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 19 Nov 2012 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Alnylam: No Approved Drugs, No Promising Candidates, No Justification For $1 Billion Valuation</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1007191-alnylam-no-approved-drugs-no-promising-candidates-no-justification-for-1-billion-valuation.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 15 Nov 2012 08:15:00 GMT</pubDate>
    </item>
    <item>
      <title>5 Healthcare Companies With Insider Buying During October 2012</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/923711-5-healthcare-companies-with-insider-buying-during-october-2012.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 15 Oct 2012 08:11:44 GMT</pubDate>
    </item>
    <item>
      <title>Intercept Pharma, Kythera Take Off in IPOs</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20121011-000448&amp;cid=1244</link>
      <author>Smart Money</author>
      <pubDate>Thu, 11 Oct 2012 11:47:00 GMT</pubDate>
    </item>
    <item>
      <title>IPO Preview: KYTHERA Biopharmaceuticals</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/916851-ipo-preview-kythera-biopharmaceuticals.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 10 Oct 2012 15:48:44 GMT</pubDate>
    </item>
    <item>
      <title>IPO Preview: Intercept Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/916811-ipo-preview-intercept-pharmaceuticals.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 10 Oct 2012 15:42:09 GMT</pubDate>
    </item>
    <item>
      <title>6 Companies That Dared to Go Public</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/10/08/6-companies-that-dared-to-go-public/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 08 Oct 2012 14:15:00 GMT</pubDate>
    </item>
  </channel>
</rss>
